BERLIN (Reuters) – Beer cannot be marketed as beneficial, a German top court ruled on Thursday after a consumer rights group sued a brewery on the basis that its advertisement falsely suggested the beer had health benefits.
Source: Reuters Medical News
KINSHASA (Reuters) – Congolese and U.N. officials were racing to prevent a runaway Ebola outbreak in Congo on Thursday, working out the logistics of keeping newly arrived vaccines well below freezing in a steamy region on the equator with unreliable power.
Source: Reuters Medical News
KINSHASA (Reuters) – Congo Health Minister Oly Ilunga Kalenga late on Wednesday said in a statement that the country’s Ebola outbreak had entered “a new phase” after a case of the virus was detected in the northwest city of Mbandaka, with a population of about 1 million people.
Source: Reuters Medical News
(Reuters) – The U.S. Food and Drug Administration said on Wednesday the harvest season for romaine lettuce, linked to the multi-state E. coli outbreak, was over and it was unlikely that it was still available in stores due to its 21-day shelf life.
Source: Reuters Medical News
(Reuters) – Roche’s immunotherapy Tecentriq, given with its older drug Avastin and chemotherapy, improved survival of advanced lung cancer patients by about 30 percent over the combination without Tecentriq, according to interim results of a late stage trial released on Wednesday.
Source: Reuters Medical News
NEW YORK (Reuters) – Allergan Inc was sued on Wednesday by four large U.S. retailers that accused the drugmaker of antitrust violations for trying to stop rivals from selling generic versions of Restasis, its medication to treat dry-eye disease.
Source: Reuters Medical News
(Reuters) – The combination of Merck & Co’s immunotherapy Keytruda and chemotherapy boosted response rates in patients with advanced hard-to-treat squamous cell lung cancer, the company said on Wednesday.
Source: Reuters Medical News
COPENHAGEN/FRANKFURT (Reuters) – Hearing aid makers Widex and Sivantos are merging to create an industry number three that can invest more in digital devices and step up the challenge to market leaders Sonova and William Demant.
Source: Reuters Medical News
(Reuters) – U.S. health regulators on Wednesday declined to approve Evolus Inc’s rival product to Allergan Plc’s Botox, citing deficiencies related to the chemistry and manufacturing of its potential treatment for frown lines, sending its shares down as much as 35 percent.
Source: Reuters Medical News
KINSHASA (Reuters) – The first batch of 4,000 experimental Ebola vaccines to combat an outbreak suspected to have killed 20 people arrived in Congo’s capital Kinshasa on Wednesday, said a Reuters witness at the airport.
Source: Reuters Medical News